Similar articles

• [The use of 131I in the combined modality therapy of highly differentiated cancer of the thyroid gland].

  Baranauskas ZL, Mamontov VV, Valutskas KK. Baranauskas ZL, et al. Med Radiol (Mosk). 1989 Oct;34(10):31-4. Med Radiol (Mosk). 1989. PMID: 2811625 Russian.
• [Indications for and against the treatment of thyroid cancer with radioactive iodine].

  Wieckowski B, Skrzypek J. Wieckowski B, et al. Pol Tyg Lek. 1983 Apr 18;38(16):501-3. Pol Tyg Lek. 1983. PMID: 6634495 Polish. No abstract available.
• Experience in the management of thyroid carcinoma by I-131. A report of 39 cases.

  Bricout P, Kibler RS. Bricout P, et al. J Can Assoc Radiol. 1973 Dec;24(4):323-7. J Can Assoc Radiol. 1973. PMID: 4773908 No abstract available.
• Proceedings: Management of cancer of the thyroid: a summary.

  Strong EW. Strong EW. Proc Natl Cancer Conf. 1972;7:179-85. Proc Natl Cancer Conf. 1972. PMID: 4587645 Review. No abstract available.
• Radioiodine therapy for papillary and follicular thyroid carcinoma.

  Klain M, Ricard M, Leboulleux S, Baudin E, Schlumberger M. Klain M, et al. Eur J Nucl Med Mol Imaging. 2002 Aug;29 Suppl 2:S479-85. doi: 10.1007/s00259-002-0810-9. Epub 2002 May 9. Eur J Nucl Med Mol Imaging. 2002. PMID: 12192549 Review.